Absence of PNET formation and normal longevity in a mouse model of Mahvash disease

Mahvash disease, a rare autosomal recessive metabolic disorder characterized by biallelic loss-of-function mutations in the glucagon receptor gene (GCGR), induces significant pancreatic hyperglucagonemia, resulting in α-cell hyperplasia and occasional hypoglycemia. Utilizing CRISPR-Cas9 technology,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heliyon 2024-08, Vol.10 (15), p.e35362, Article e35362
Hauptverfasser: Xu, Yingna, Liu, Qiaofeng, Chen, Chuan-Wei, Wang, Qiuying, Du, Tianyuan, Yu, Run, Zhou, Qingtong, Yang, Dehua, Wang, Ming-Wei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Mahvash disease, a rare autosomal recessive metabolic disorder characterized by biallelic loss-of-function mutations in the glucagon receptor gene (GCGR), induces significant pancreatic hyperglucagonemia, resulting in α-cell hyperplasia and occasional hypoglycemia. Utilizing CRISPR-Cas9 technology, we engineered a mouse model, designated as GcgrV369M/V369M, harboring a homozygous V369M substitution in the glucagon receptor (GCGR). Although wild-type (WT) and GcgrV369M/V369M mice exhibited no discernible difference in appearance or weight, adult GcgrV369M/V369M mice, approximately 12 months of age, displayed a notable decrease in fasting blood glucose levels and elevated the levels of cholesterol and low-density lipoprotein-cholesterol. Moreover, plasma amino acid levels such as alanine (Ala), proline (Pro) and arginine (Arg) were elevated in GcgrV369M/V369M mice contributing to α-cell proliferation and hyperglucagonemia. Despite sustained α-cell hyperplasia and increased circulating glucagon levels in GcgrV369M/V369M mice, metabolic disparities between the two groups gradually waned with age accompanied by a reduction in α-cell hyperplasia. Throughout the lifespan of the mice (up to approximately 30 months), pancreatic neuroendocrine tumors (PNETs) did not manifest. This prolonged observation of metabolic alterations in GcgrV369M/V369M mice furnishes valuable insights for a deeper comprehension of mild Mahvash disease in humans. Our study demonstrates that GcgrV369M/V369M mice exhibited reduction in fasting blood glucose levels, hyperaminoacidemia and α-cell hyperplasia with elevated GCG levels. However, metabolic disparities between WT and GcgrV369M/V369M mice waned with age. [Display omitted] •A mild Mahvash disease mouse model (GcgrV369M/V369M mice) was developed.•GcgrV369M/V369M mice exhibited reduced fasting blood glucose, hyperaminoacidemia and α-cell hyperplasia with elevated glucagon levels.•Metabolic disparities between WT mice and GcgrV369M/V369M mice waned with age.
ISSN:2405-8440
2405-8440
DOI:10.1016/j.heliyon.2024.e35362